John Breitner on In Alzheimer’s, More TREM2 Is Good for You
COMMENT These findings fit quite elegantly with our recent findings and hypothesis that innate immune activity modulates development of presymptomatic AD, and that markers of immune activation are generally beneficial (Meyer et al., 2019). For various reasons we ...